• Methotrexate as a Folate Antagonist: Applied Workflows & Ass

  2026-06-08

  Methotrexate’s dual action as a folate antagonist and immunosuppressive agent empowers researchers with reproducible control in apoptosis and inflammation assays. This guide distills advanced workflows, troubleshooting insights, and protocol optimizations to maximize experimental reliability using APExBIO’s rigorously validated Methotrexate.

• Pam3CSK4 TFA: Precision TLR1/2 Agonist for Innate Immunity R

  2026-06-08

  Pam3CSK4 TFA is a synthetic TLR1/2 agonist enabling robust and reproducible activation of innate immune responses in vitro and in vivo. Its high purity and validated solubility profile facilitate controlled studies on inflammatory signaling and cytokine production. This dossier details evidence, applications, and workflow guidance for researchers.

• Losartan as an Angiotensin II Receptor Antagonist in Hyperte

  2026-06-07

  Losartan's high-affinity AT1 receptor antagonism enables precise dissection of angiotensin II signaling in cardiovascular and renal models. This article delivers actionable protocol guidance, advanced troubleshooting, and translational insights anchored in recent innovations and cross-domain research.

• Fe3O4@ZIF-8 Nanoparticles: Dual Antibiosis and Osteogenesis

  2026-06-06

  This study introduces Fe3O4@ZIF-8 core–shell nanoparticles engineered for the simultaneous control of infection and bone regeneration in jaw osteomyelitis. Through pH-responsive Zn2+ release and magnetic field-assisted osteogenesis, the platform addresses antibiotic resistance and persistent bone defects, highlighting a promising translational route for complex oral infections.

• Disrupting SARS-CoV-2 Nucleocapsid Condensation to Inhibit R

  2026-06-05

  The referenced study uncovers how SARS-CoV-2 replication depends on RNA-triggered liquid–liquid phase separation (LLPS) of its nucleocapsid (N) protein, and reveals that (-)-gallocatechin gallate (GCG) can disrupt this process, suppressing viral propagation. These findings highlight biomolecular condensation as a pivotal target for antiviral intervention and expand the toolkit for phase separation and protein interaction research.

• FH1 Small Molecule: Elevating Hepatocyte Function for Next-G

  2026-06-05

  Explore how the FH1 small molecule uniquely enhances cultured hepatocyte maturity, bridging stem cell biology and optogenetic gene control for advanced liver research. Gain new practical insights into protocol optimization and translational readiness.

• Novel AR Antagonists Target Dimer Interface to Overcome Resi

  2026-06-04

  This study reports the discovery of N‐(1,2,4-thiadiazol-5-yl)benzo[b]oxepine-4-carboxamide derivatives as antiresistance androgen receptor (AR) antagonists. By targeting the AR dimer interface rather than the classical ligand-binding pocket, these compounds disrupt AR function and overcome key drug-resistant mutations, providing new strategies for prostate cancer therapy.

• DR5 Agonist Antibodies Drive ROCK1-Mediated PD-L1 Stabilizat

  2026-06-04

  This study uncovers a previously unrecognized mechanism in which DR5 agonist antibodies, intended to induce tumor apoptosis, inadvertently stabilize PD-L1 via ROCK1 activation, promoting immune evasion in triple-negative breast, ovarian, and other solid tumors. These findings suggest that combining DR5 agonists with targeted ROCK inhibition could revive immunotherapeutic efficacy in resistant solid tumors.

• Ionomycin Free Acid: Unlocking Calcium Ionophore Precision i

  2026-06-03

  Explore how Ionomycin free acid, a powerful calcium ionophore, enables precise intracellular calcium modulation for advanced research—including oocyte activation and cancer signaling. This article delivers a deep dive into mechanisms, assay optimization, and new insights from FAK–calcium dynamics.

• Methyl-β-cyclodextrin: Technical Guide for Membrane Choleste

  2026-06-03

  Methyl-β-cyclodextrin is a high-purity cyclic oligosaccharide used for membrane cholesterol extraction and modulation of membrane fluidity in cell-based research workflows. It is not suitable for diagnostic or medical use and requires precise handling and storage to maintain efficacy. This guide outlines technical parameters, workflow setup, and troubleshooting for reliable experimental outcomes.

• Superoxide Dismutase Activity Assay Kit: Precision in Redox

  2026-06-02

  The Superoxide Dismutase (SOD) Activity Assay Kit by APExBIO empowers researchers with a streamlined, quantitative solution for SOD activity measurement across diverse biological samples. Explore how its colorimetric workflow, robust data output, and informed troubleshooting set a new standard for oxidative stress assays in translational science.

• Streptavidin – Cy5: Precision Biotin Detection in Cell Assay

  2026-06-02

  Streptavidin – Cy5 from APExBIO empowers high-sensitivity biotin detection in immunofluorescence, IHC, and flow cytometry. Its robust Cy5 fluorescent dye conjugation supports reproducible, multiplexed workflows for advanced cancer and cell signaling research.

• BRD4770 in Context: Precision Epigenetic Modulation for Canc

  2026-06-01

  Explore how BRD4770, a selective G9a histone methyltransferase inhibitor, enables advanced exploration of epigenetic regulation and cellular senescence in cancer models. This in-depth article reveals unique mechanistic insights and practical protocols for deploying BRD4770 in cancer biology research.

• OTUD3 Stabilization of SLC7A11 Drives Sunitinib Resistance i

  2026-06-01

  This study uncovers how OTUD3-mediated stabilization of the cystine transporter SLC7A11 suppresses ferroptosis, thereby promoting resistance to the multi-kinase inhibitor sunitinib in clear cell renal cell carcinoma (ccRCC). The findings pinpoint the OTUD3–SLC7A11 axis as a key modulator of therapeutic response and a promising target to overcome drug resistance in advanced ccRCC.

• Cefiderocol Activity Against Resistant Pseudomonas and Acine

  2026-05-31

  This study provides the first large-scale comparison of cefiderocol and β-lactam/β-lactamase inhibitor combinations against carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Europe. The findings highlight cefiderocol's superior in vitro efficacy, even in multidrug-resistant isolates, informing future therapeutic strategies and resistance surveillance.

473 records 10/32 page Previous Next First page 上5页 678910 下5页 Last page